Key result
Targeting SBP 120-130 mm Hg with CCBs or ARBs is linked to lower dementia risk.
Why the study?
Hypertension is a risk factor for cognitive decline, but blood pressure treatments and optimal targets relative to cognitive outcomes remain controversial, especially regarding potential consequences if targets are too aggressive.
Does blood pressure lowering treatment and targeting SBP 120-130 mm Hg reduce the risk of dementia in elderly patients with hypertension?
Does blood pressure lowering treatment and targeting SBP 120-130 mm Hg reduce the risk of dementia in elderly patients with hypertension?
Targeting a systolic blood pressure of 120-130 mm Hg and utilizing CCBs or ARBs may reduce the risk of dementia in older hypertensive patients, though personalized care is essential for the frail and oldest old.
May support SBP 120-130 mm Hg targets with CCBs/ARBs for lower dementia risk in older hypertensives; hypothesis-generating, RCTs needed before practice change.
Hypertension is an important public health concern. The prevalence keeps increasing, and it is a risk factor for several adverse health outcomes including a decline in cognitive function. Recent data also show that the prevalence of hypertension and age-related dementia is rising in Asian countries, including in the oldest old group. This study aims to discuss possible treatments for high blood pressure in the elderly and propose an optimal target for BP relative to cognitive outcomes. This review discusses several studies on related blood pressure treatments that remain controversial and the consequences if the treatment target is too low or aggressive. Longitudinal, cross-sectional, and RCT studies were included in this review. An optimum systolic blood pressure of 120-130 mm Hg is recommended, especially in nondiabetic hypertensive patients with significant risk factors. In the oldest old group of patients, hypertension might have a protective effect. The use of calcium channel blockers (CCB) and angiotensin receptor blocker (ARB) is independently associated with a decreased risk of dementia in older people. However, personalized care for patients with hypertension, especially for patients who are frail or very old, is encouraged.
No takes yet. Share an insight, caveat, or question.
Turana et al. (2019) conducted a review in Hypertension and dementia. Blood pressure lowering (CCB, ARB) was evaluated on Cognitive outcomes and dementia risk. Targeting a systolic blood pressure of 120-130 mm Hg and using calcium channel blockers or angiotensin receptor blockers are associated with a decreased risk of dementia in older people.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: